| Q38037888 | Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers |
| Q44845368 | Alkaline citrates in urology. A status report |
| Q37585262 | CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update |
| Q46301188 | Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study |
| Q44748165 | Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis |
| Q24186599 | Citrate salts for preventing and treating calcium containing kidney stones in adults |
| Q24201267 | Citrate salts for preventing and treating kidney stones |
| Q46534609 | Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients |
| Q35335724 | Clinical practice. Calcium kidney stones |
| Q34265048 | Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management |
| Q104558869 | Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy with Kidney Stone Recurrence |
| Q36325704 | Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline |
| Q44199296 | Effect of acute load of grapefruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation |
| Q47919786 | Effectiveness of Treatment Modalities on Kidney Stone Recurrence |
| Q24630579 | Evaluation and medical management of the kidney stone patient |
| Q37633953 | Hypocitraturia: pathophysiology and medical management. |
| Q38906968 | Idiopathic hypercalciuria and formation of calcium renal stones |
| Q98564786 | Innovative prolonged-release oral alkalising formulation allowing sustained urine pH increase with twice daily administration: randomised trial in healthy adults |
| Q24536113 | Kidney stone disease |
| Q37169623 | Kidney stones: an update on current pharmacological management and future directions |
| Q43095592 | Long-term treatment of renal lithiasis with potassium citrate |
| Q39726042 | Longitudinal study of bone mineral density in children with idiopathic hypercalciuria |
| Q36891913 | Mechanisms of disease: what can mouse models tell us about the molecular processes underlying Dent disease? |
| Q42250628 | Medical Measures for Secondary Prevention of Urolithiasis |
| Q26777616 | Medical and alternative therapies in urinary tract stone disease |
| Q37360241 | Medical therapy of stone disease: from prevention to promotion of passage options |
| Q38270121 | Metabolic evaluation of urinary lithiasis: what urologists should know and do. |
| Q81295660 | Nephrolithiasis |
| Q34936324 | Nephrolithiasis-associated bone disease: pathogenesis and treatment options |
| Q40330414 | Patients' attitudes on how to deal with the risk of future stone recurrences |
| Q36033738 | Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies. |
| Q38062189 | Pharmacologic treatment of kidney stone disease |
| Q34936294 | Pharmacology of stone disease |
| Q34936200 | Pharmacotherapy of urolithiasis: evidence from clinical trials |
| Q28248699 | Preventive treatment of nephrolithiasis with alkali citrate--a critical review |
| Q46471961 | Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial |
| Q41536017 | Prospective therapeutic studies in nephrolithiasis |
| Q58118264 | Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date? |
| Q31057241 | Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature |
| Q96427835 | The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment |
| Q45352827 | The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers |
| Q46123360 | Urinary citrate levels do not correlate with urinary pH in patients with urinary stone formation |
| Q39119052 | Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. |
| Q37357212 | Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial. |
| Q79375339 | [Evidence-based pharmacological metaphylaxis of stone disease] |
| Q79795058 | [Prevention of nephrolithiasis. Established strategies and new concepts] |
| Q87714084 | [S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium] |